Literature DB >> 11342162

Effects of inhibitors of the vacuolar proton pump on hepatic heterophagy and autophagy.

S A Mousavi1, R Kjeken, T O Berg, P O Seglen, T Berg, A Brech.   

Abstract

Bafilomycin A(1) (BAF) and concanamycin A (ConcA) are selective inhibitors of the H(+)-ATPases of the vacuolar system. We have examined the effects of these inhibitors on different steps in endocytic pathways in rat hepatocytes, using [(125)I]tyramine-cellobiose-labeled asialoorosomucoid ([(125)I]TC-AOM) and [(125)I]tyramine-cellobiose-labeled bovine serum albumin ([(125)I]TC-BSA) as probes for respectively receptor-mediated endocytosis and pinocytosis (here defined as fluid phase endocytosis). The effects of BAF and ConcA were in principle identical, although ConcA was more effective than BAF. The main findings were as follows. (1) BAF/ConcA reduced the rate of uptake of both [(125)I]TC-AOM and [(125)I]TC-BSA. The reduced uptake of [(125)I]TC-AOM was partly due to a redistribution of the asialoglycoprotein receptors (ASGPR) such that the number of surface receptors was reduced approximately 40% without a change in the total number of receptors. (2) BAF/ConcA at the same time increased retroendocytosis (recycling) of both probes. The increased recycling of the ligand ([(125)I]TC-AOM) is partly a consequence of the enhanced pH in endosomes, which prevents dissociation of ligand. (3) It was furthermore found that the ligand remained bound to the receptor in presence of BAF/ConcA and that the total amount of ligand molecules internalized in BAF/ConcA-treated cells was only slightly in excess of the total number of receptors. These data indicate that reduced pH in endosomes is the prime cause of receptor inactivation and release of ligand in early endosomes. (4) Subcellular fractionation experiments showed that [(125)I]TC-AOM remained in early endosomes, well separated from lysosomes in sucrose gradients. The fluid phase marker, [(125)I]TC-BSA, on the other hand, seemed to reach a later endosome in the BAF/ConcA-treated cells. This organelle coincided with lysosomes in the gradient, but hypotonic medium was found to selectively release a lysosomal enzyme (beta-acetylglucosaminidase), indicating that even [(125)I]TC-BSA remained in a prelysosomal compartment in the BAF/ConcA-treated cells. (5) Electron microscopy using horseradish peroxidase (HRP) as a fluid phase marker verified that BAF/ConcA inhibited transfer of material from late endosomes ('multivesicular bodies'). (6) BAF/ConcA led to accumulation of lactate dehydrogenase (LDH) in autophagic vacuoles, but although the drugs partly inhibited fusion between autophagosomes and lysosomes a number of autolysosomes was formed in the presence of BAF/ConcA. This observation explains the reduced buoyant density of lysosomes (revealed in sucrose density gradients). In conclusion, BAF/ConcA inhibit transfer of endocytosed material from late endosomes to lysosomes, but do not at the same time prevent fusion between autophagosomes and lysosomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342162     DOI: 10.1016/s0005-2736(00)00354-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1.

Authors:  Behzad Yeganeh; Saeid Ghavami; Andrea L Kroeker; Thomas H Mahood; Gerald L Stelmack; Thomas Klonisch; Kevin M Coombs; Andrew J Halayko
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes.

Authors:  Rosa M Andrade; Matthew Wessendarp; Marc-Jan Gubbels; Boris Striepen; Carlos S Subauste
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

Review 3.  How positive-strand RNA viruses benefit from autophagosome maturation.

Authors:  Alexsia L Richards; William T Jackson
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

Review 4.  Stress-induced self-cannibalism: on the regulation of autophagy by endoplasmic reticulum stress.

Authors:  Shane Deegan; Svetlana Saveljeva; Adrienne M Gorman; Afshin Samali
Journal:  Cell Mol Life Sci       Date:  2012-09-28       Impact factor: 9.261

5.  Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition.

Authors:  Karin von Schwarzenberg; Romina M Wiedmann; Prajakta Oak; Sabine Schulz; Hans Zischka; Gerhard Wanner; Thomas Efferth; Dirk Trauner; Angelika M Vollmar
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

6.  Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro.

Authors:  Po-Yuan Ke; Steve S-L Chen
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

7.  Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes.

Authors:  Seyed Ali Mousavi; Andreas Brech; Trond Berg; Rune Kjeken
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

8.  The TP53INP2 protein is required for autophagy in mammalian cells.

Authors:  Jonathan Nowak; Cendrine Archange; Joël Tardivel-Lacombe; Pierre Pontarotti; Marie-Josèphe Pébusque; Maria Inés Vaccaro; Guillermo Velasco; Jean-Charles Dagorn; Juan Lucio Iovanna
Journal:  Mol Biol Cell       Date:  2008-12-03       Impact factor: 4.138

9.  Acetylated microtubules are required for fusion of autophagosomes with lysosomes.

Authors:  Rui Xie; Susan Nguyen; Wallace L McKeehan; Leyuan Liu
Journal:  BMC Cell Biol       Date:  2010-11-22       Impact factor: 4.241

10.  Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis.

Authors:  Qingli Xiao; Ping Yan; Xiucui Ma; Haiyan Liu; Ronaldo Perez; Alec Zhu; Ernesto Gonzales; Jack M Burchett; Dorothy R Schuler; John R Cirrito; Abhinav Diwan; Jin-Moo Lee
Journal:  J Neurosci       Date:  2014-07-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.